MERRIMACK PHARMACEUTICALS INC 4
4 · MERRIMACK PHARMACEUTICALS INC · Filed Dec 13, 2013
Insider Transaction Report
Form 4
McClements William M.
SVP of Corporate Operations
Transactions
- Purchase
Common Stock
2013-12-12$4.39/sh+2,500$10,981→ 13,000 total - Purchase
Common Stock
2013-12-11$4.05/sh+1,500$6,078→ 10,500 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.0299 to $4.0793, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.2899 to $4.4567, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.